Avantor, Inc. Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent
Avantor, Inc. (AVTR) reported Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent of -$22.60 million for the 3-month period ending 2026-03-31, per its 10-Q filed 2026-04-29.
Financial Statements › Income Statement › Unrealized Gains
us-gaap:OtherComprehensiveIncomeLossBeforeTaxPortionAttributableToParent · last filed 2026-04-29
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for the quarter ending 2026-03-31 was -$22.60M, a 138.57% decline year-over-year.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for the quarter ending 2025-12-31 was $15.00M.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for the quarter ending 2025-09-30 was -$12.00M, a 164.52% decline year-over-year.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for the quarter ending 2025-06-30 was $89.70M.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for fiscal 2025 was $151.30M.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for fiscal 2024 was -$110.60M, a 837.33% decline from fiscal 2023.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for fiscal 2023 was $15.00M.
- Avantor, Inc. other comprehensive income (loss), before tax, portion attributable to parent for fiscal 2022 was -$29.40M.
| Period end | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent 3 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent 6 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent 9 month | Other Comprehensive Income (Loss), before Tax, Portion Attributable to Parent 12 month |
|---|---|---|---|---|
| 2026-03-31 | -$22.60M 10-Q · filed 2026-04-29 | -$7.60M derived: sum of 2 quarters · filed 2026-04-29 | -$19.60M derived: sum of 3 quarters · filed 2026-04-29 | $70.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-12-31 | $15.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | $3.00M derived: sum of 2 quarters · filed 2026-02-11 | $92.70M derived: sum of 3 quarters · filed 2026-02-11 | $151.30M 10-K · filed 2026-02-11 |
| 2025-09-30 | -$12.00M 10-Q · filed 2025-10-29 | $77.70M derived: sum of 2 quarters · filed 2025-10-29 | $136.30M 10-Q · filed 2025-10-29 | $37.30M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-06-30 | $89.70M 10-Q · filed 2025-08-01 | $148.30M 10-Q · filed 2025-08-01 | $49.30M derived: sum of 3 quarters · filed 2026-04-29 | $67.90M derived: sum of 4 quarters · filed 2026-04-29 |
| 2025-03-31 | $58.60M 10-Q · filed 2026-04-29 | -$40.40M derived: sum of 2 quarters · filed 2026-04-29 | -$21.80M derived: sum of 3 quarters · filed 2026-04-29 | -$31.10M derived: sum of 4 quarters · filed 2026-04-29 |
| 2024-12-31 | -$99.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$80.40M derived: sum of 2 quarters · filed 2026-02-11 | -$89.70M derived: sum of 3 quarters · filed 2026-02-11 | -$110.60M 10-K · filed 2026-02-11 |
| 2024-09-30 | $18.60M 10-Q · filed 2025-10-29 | $9.30M derived: sum of 2 quarters · filed 2025-10-29 | -$11.60M 10-Q · filed 2025-10-29 | $12.60M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-06-30 | -$9.30M 10-Q · filed 2025-08-01 | -$30.20M 10-Q · filed 2025-08-01 | -$6.00M derived: sum of 3 quarters · filed 2026-02-11 | -$37.70M derived: sum of 4 quarters · filed 2026-02-11 |
| 2024-03-31 | -$20.90M 10-Q · filed 2025-04-25 | $3.30M derived: sum of 2 quarters · filed 2026-02-11 | -$28.40M derived: sum of 3 quarters · filed 2026-02-11 | -$11.30M derived: sum of 4 quarters · filed 2026-02-11 |
| 2023-12-31 | $24.20M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-11 | -$7.50M derived: sum of 2 quarters · filed 2026-02-11 | $9.60M derived: sum of 3 quarters · filed 2026-02-11 | $15.00M 10-K · filed 2026-02-11 |
| 2023-09-30 | -$31.70M 10-Q · filed 2024-10-25 | -$14.60M derived: sum of 2 quarters · filed 2024-10-25 | -$9.20M 10-Q · filed 2024-10-25 | $90.50M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-06-30 | $17.10M 10-Q · filed 2024-07-26 | $22.50M 10-Q · filed 2024-07-26 | $122.20M derived: sum of 3 quarters · filed 2025-02-07 | $80.90M derived: sum of 4 quarters · filed 2025-02-07 |
| 2023-03-31 | $5.40M 10-Q · filed 2024-04-26 | $105.10M derived: sum of 2 quarters · filed 2025-02-07 | $63.80M derived: sum of 3 quarters · filed 2025-02-07 | -$1.00M derived: sum of 4 quarters · filed 2025-02-07 |
| 2022-12-31 | $99.70M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-07 | $58.40M derived: sum of 2 quarters · filed 2025-02-07 | -$6.40M derived: sum of 3 quarters · filed 2025-02-07 | -$29.40M 10-K · filed 2025-02-07 |
| 2022-09-30 | -$41.30M 10-Q · filed 2023-10-27 | -$106.10M derived: sum of 2 quarters · filed 2023-10-27 | -$129.10M 10-Q · filed 2023-10-27 | -$128.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-06-30 | -$64.80M 10-Q · filed 2023-07-28 | -$87.80M 10-Q · filed 2023-07-28 | -$87.50M derived: sum of 3 quarters · filed 2024-02-14 | -$124.20M derived: sum of 4 quarters · filed 2024-02-14 |
| 2022-03-31 | -$23.00M 10-Q · filed 2023-04-28 | -$22.70M derived: sum of 2 quarters · filed 2024-02-14 | -$59.40M derived: sum of 3 quarters · filed 2024-02-14 | -$42.80M derived: sum of 4 quarters · filed 2024-02-14 |
| 2021-12-31 | $300.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-14 | -$36.40M derived: sum of 2 quarters · filed 2024-02-14 | -$19.80M derived: sum of 3 quarters · filed 2024-02-14 | -$52.90M 10-K · filed 2024-02-14 |
| 2021-09-30 | -$36.70M 10-Q · filed 2022-10-28 | -$20.10M derived: sum of 2 quarters · filed 2022-10-28 | -$53.20M 10-Q · filed 2022-10-28 | $13.40M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-06-30 | $16.60M 10-Q · filed 2022-07-29 | -$16.50M 10-Q · filed 2022-07-29 | $50.10M derived: sum of 3 quarters · filed 2023-02-14 | $104.10M derived: sum of 4 quarters · filed 2023-02-14 |
| 2021-03-31 | -$33.10M 10-Q · filed 2022-04-29 | $33.50M derived: sum of 2 quarters · filed 2023-02-14 | $87.50M derived: sum of 3 quarters · filed 2023-02-14 | $131.90M derived: sum of 4 quarters · filed 2023-02-14 |
| 2020-12-31 | $66.60M derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-14 | $120.60M derived: sum of 2 quarters · filed 2023-02-14 | $165.00M derived: sum of 3 quarters · filed 2023-02-14 | $98.00M 10-K · filed 2023-02-14 |
| 2020-09-30 | $54.00M 10-Q · filed 2021-10-29 | $98.40M derived: sum of 2 quarters · filed 2021-10-29 | $31.40M 10-Q · filed 2021-10-29 | $67.90M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-06-30 | $44.40M 10-Q · filed 2021-07-30 | -$22.60M 10-Q · filed 2021-07-30 | $13.90M derived: sum of 3 quarters · filed 2022-02-11 | -$49.00M derived: sum of 4 quarters · filed 2022-02-11 |
| 2020-03-31 | -$67.00M 10-Q · filed 2021-04-28 | -$30.50M derived: sum of 2 quarters · filed 2022-02-11 | -$93.40M derived: sum of 3 quarters · filed 2022-02-11 | -$82.30M derived: sum of 4 quarters · filed 2022-02-11 |
| 2019-12-31 | $36.50M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-11 | -$26.40M derived: sum of 2 quarters · filed 2022-02-11 | -$15.30M derived: sum of 3 quarters · filed 2022-02-11 | -$25.10M 10-K · filed 2022-02-11 |
| 2019-09-30 | -$62.90M 10-Q · filed 2020-10-27 | -$51.80M derived: sum of 2 quarters · filed 2020-10-27 | -$61.60M 10-Q · filed 2020-10-27 | -$98.30M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-06-30 | $11.10M 10-Q · filed 2020-07-29 | $1.30M 10-Q · filed 2020-07-29 | -$35.40M derived: sum of 3 quarters · filed 2021-02-16 | -$37.20M derived: sum of 4 quarters · filed 2021-02-16 |
| 2019-03-31 | -$9.80M 10-Q · filed 2020-04-29 | -$46.50M derived: sum of 2 quarters · filed 2021-02-16 | -$48.30M derived: sum of 3 quarters · filed 2021-02-16 | -$134.50M derived: sum of 4 quarters · filed 2021-02-16 |
| 2018-12-31 | -$36.70M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-16 | -$38.50M derived: sum of 2 quarters · filed 2021-02-16 | -$124.70M derived: sum of 3 quarters · filed 2021-02-16 | -$96.20M 10-K · filed 2021-02-16 |
| 2018-09-30 | -$1.80M 10-Q · filed 2019-11-05 | -$88.00M derived: sum of 2 quarters · filed 2019-11-05 | -$59.50M 10-Q · filed 2019-11-05 | |
| 2018-06-30 | -$86.20M 10-Q · filed 2019-08-06 | -$57.70M 10-Q · filed 2019-08-06 | ||
| 2017-12-31 | $70.40M 10-K · filed 2020-02-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| REVVITY, INC. (RVTY) | United States | $16.814B | 53.44 |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |
| Seer, Inc. (SEER) | United States | $0.104B | -1.34 |